Survival in Patients with Early Breast Cancer Treated with Conservative Surgery and Radiotherapy at the National Cancer Institute of Colombia

Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005;6:391-401.

https://doi.org/10.3816/CBC.2005.n.043

Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358:213-6.

https://doi.org/10.1056/NEJMp0708307

Ferlay J, Shin HR, Bray F, et al. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; 2010.

Chopra R. The Indian scene. J Clin Oncol. 2001;19:S106-11.

Schwartsmann G. Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol. 2001;19:S118-24.

Piñeros M, Sánchez R, Cendales R, et al. Características sociodemográficas, clínicas y de la atención de mujeres con cáncer de mama en Bogotá. Rev Colomb Cancerol. 2008;12:181-90.

Arboleda W, Murillo R, Piñeros R, et al. Cobertura de examen clínico y mamografía de tamización para cáncer de mama en mujeres. Rev Colomb Cancerol. 2009;13:69-76.

https://doi.org/10.1016/S0123-9015(09)70138-6

Robledo JF, Caicedo JJ, DeAntonio R. Análisis de sobrevida en una cohorte de 1328 pacientes con carcinoma de seno. Rev Colomb Cir. 2005;20:4-20.

Murillo RH, Piñeros M, Pardo C, et al. Anuario Estadístico 2006 Por el control del cáncer. Bogotá: Instituto Nacional de Cancerología [internet]. 2007 [citado: 25 de enero del 2009]. Disponible en: http://www.incancerologia.gov.co/documentos/1_3_2008_10_21_58_AM_anuario%20estadistico.pdf.

Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-36.

https://doi.org/10.1200/JCO.2002.02.026

Blichert-Toft M, Nielsen M, Düring M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol. 2008;47:672-81.

https://doi.org/10.1080/02841860801971439

Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41.

https://doi.org/10.1056/NEJMoa022152

Noël G, Mazeron JJ. [Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial]. Cancer Radiother. 2001;5:211-2. [Artículo en francés].

https://doi.org/10.1016/S1278-3218(00)00082-2

Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-32.

https://doi.org/10.1056/NEJMoa020989

Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-106.

https://doi.org/10.1016/S0140-6736(05)67887-7

Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Rosalba Ospino, Ricardo Cendales, Zayda Sánchez, Iván Bobadilla, Juan Galvis, Javier Cifuentes results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963-8.

https://doi.org/10.1200/JCO.1997.15.3.963

Bartelink H, Horiot JC, Poortmans P, et al Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378-87.

https://doi.org/10.1056/NEJMoa010874

Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27:1062-8.

https://doi.org/10.1200/JCO.2008.18.6965

República de Colombia. Ministerio de Salud. Resolución 8430 de 1993 (4 de octubre), por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Bogotá: Ministerio de Salud; 1996.

Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy: a 27-year singleinstitution experience. Cancer. 2005;104:20-9.

https://doi.org/10.1002/cncr.21121

República de Colombia. Instituto Nacional de Cancerología. Recomendaciones para la tamización y la detección temprana del cáncer de mama en Colombia [internet]. 2006 [citado: 12 de octubre del 2009]. Disponible en: http://www.cancer.gov.co/documentos/769_guiaN1.pdf.

Grann VR, Troxel AB, Zojwalla NJ, et al. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. 2005;103:2241-51.

https://doi.org/10.1002/cncr.21030

Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-312.

https://doi.org/10.1200/JCO.2007.14.2364

Scottish Intercollegiate Guidelines Network (SIGN). SIGN 84: Management of breast cancer in women [internet]. 2005 [citado: 18 de enero del 2009]. Disponible en: http://www.sign.ac.uk/pdf/sign84.pdf.

National Comprehensive Cancer Network. Clinical practice guidelines in oncology: breast cancer - version V.1.2010. NCCN [internet]. 2010 [citado: 29 de abril del 2010]. Disponible en: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.

Sautter-Bihl ML, Budach W, Dunst J, et al. DEGRO practical guidelines for radiotherapy of breast cancer I: breastconserving therapy. Strahlenther Onkol. 2007;183:661-6.

https://doi.org/10.1007/s00066-007-1811-1

Poortmans PM, Collette L, Horiot JC, et al. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol. 2009;90:80-5.

https://doi.org/10.1016/j.radonc.2008.07.011

Poortmans PM, Collette L, Bartelink H, et al. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. Cancer Radiother. 2008;12:565-70.

https://doi.org/10.1016/j.canrad.2008.07.014

Crowe JP Jr, Gordon NH, Hubay CA, et al. Estrogen receptor determination and long term survival of patients with carcinoma of the breast. Surg Gynecol Obstet. 1991;173:273-8.

Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20:1319-29.

https://doi.org/10.1093/annonc/mdp322

Haffty BG, Buchholz TA. Molecular predictors of locoregional recurrence in breast cancer: ready for prime time? J Clin Oncol. 2010;28:1627-9.

https://doi.org/10.1200/JCO.2009.27.1080

Vinh-Hung V, Nguyen NP, Cserni G, et al. Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol. 2009;5:1585-603.

https://doi.org/10.2217/fon.09.129

Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21:555-63.

https://doi.org/10.1200/JCO.2003.04.171

Chen Z, King W, Pearcey R, et al. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87:3-16.

https://doi.org/10.1016/j.radonc.2007.11.016

Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97:419-24.

https://doi.org/10.1093/jnci/dji067

Roychoudhuri R, Robinson D, Putcha V, et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer. 2007;7:9.

https://doi.org/10.1186/1471-2407-7-9

Bese NS, Munshi A, Budrukkar A, et al. Breast radiation therapy guideline implementation in low- and middleincome countries. Cancer. 2008;113(8 Suppl):2305-14.

https://doi.org/10.1002/cncr.23838

Ospino Peña R, Vásquez Aponte I, Cendales R, et al. Radioterapia conformada en pacientes con cáncer de próstata Experiencia de tres años en el Instituto Nacional de Cancerología de Colombia. Rev Colomb Cancerol. 2009;13:124-33.

https://doi.org/10.1016/S0123-9015(09)70131-3

Ospino R, Cendales R, Alonso CE. Braquiterapia de alta tasa de dosis en pacientes con cáncer de próstata. Rev Colomb Cancerol. 2008;1230-6.